Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen.

Morgan, Todd M and Welty, Christopher J and Vakar-Lopez, Funda and Lin, Daniel W and Wright, Jonathan L (2010) Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. The Journal of urology, 184 (6). pp. 2303-2307. ISSN 1527-3792

Text (Accepted manuscript) WrightJL_JUrology_050611FullManuscript.pdf - Accepted Version Restricted to Repository staff only Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (225kB)

Abstract

The clinical significance of ductal prostatic carcinoma is not well-defined. In a population based cancer registry we identified a large group of patients with ductal carcinoma to characterize the impact of the ductal subtype on presentation and survival in men with prostate cancer.

Item Type:	Article or Abstract
Additional Information:	This article is freely available in PubMed Central.
DOI:	10.1016/j.juro.2010.08.017
PubMed ID:	20952027
NIHMSID:	NIHMS294511
PMCID:	PMC3111052
Grant Numbers:	T32 CA009168
Keywords or MeSH Headings:	Adenocarcinoma/blood/mortality/pathology; Aged; Humans; Male; Middle Aged; Prostate-Specific Antigen/blood; Prostatic Neoplasms/blood/mortality/pathology; Risk Factors;
Depositing User:	Library Staff
Date Deposited:	09 May 2012 22:51
Last Modified:	09 May 2012 22:51
URI:	http://authors.fhcrc.org/id/eprint/487

Repository Administrators Only

View Item